Cargando…
Prophylaxis of hereditary breast cancer
Autores principales: | de Groot, Jolien S., van Diest, Paul J., Derksen, Patrick W.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764377/ https://www.ncbi.nlm.nih.gov/pubmed/29227964 http://dx.doi.org/10.18632/aging.101342 |
Ejemplares similares
-
αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer
por: de Groot, Jolien S, et al.
Publicado: (2018) -
Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011) -
Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice
por: de Groot, Jolien S., et al.
Publicado: (2017) -
Informed decision‐making in hereditary angioedema prophylaxis
por: Burnette, Autumn Ford
Publicado: (2021) -
Lobular breast cancer: molecular basis, mouse and cellular models
por: Christgen, Matthias, et al.
Publicado: (2015)